RV

Ram Vishwakarma

Active Director Additional Director DIN 07108315
DIN 07108315 First appointment Jul 2020 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jul 2020
Shareholding value •••• Premium profile

About Ram Vishwakarma

Data last updated:

Ram Vishwakarma has 6 years in corporate governance. Holds Additional Director and Director roles. Currently with 4 companies, including Biotech Consortium India Limited and Conjuvac (Opc) Private Limited. Formerly with 1 company, such as Galen Biopharma India Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹7.25 Cr; the largest is Biotech Consortium India Limited at ₹6.12 Cr (FY 2025).

DIN 07108315
Primary Designation Additional Director
First Appointment 28 Jul 2020
Oldest Company Age 36 yrs
Largest company Biotech Consortium India Limited · ₹6.12 Cr (FY 2025)
Combined revenue ₹7.25 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biotech Consortium India Limited U73100DL1990PLC041486
Additional Director28 Oct 20201990₹6.12 Cr (FY 2025)Active
Conjuvac (Opc) Private Limited U73100HR2022OPC107599
Director09 Nov 20222022₹1.13 Cr (FY 2025)Active
Onco-Vac Biopharma Private Limited U73100DL2022PTC404697
Director10 Feb 20232022₹28,383 (FY 2025)Active
Additional Director07 Dec 20212021–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jul 20202020–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biotech Consortium India Limited
Conjuvac (Opc) Private Limited
Skei Oncotherapeutics Private Limited
Onco-Vac Biopharma Private Limited
Premium access

Shareholding and investment profile for Ram Vishwakarma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Vishwakarma

Ram Vishwakarma has 6 years in corporate governance. Holds Additional Director and Director roles. Currently with 4 companies, including Biotech Consortium India Limited and Conjuvac (Opc) Private Limited. Formerly with 1 company, such as Galen Biopharma India Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹7.25 Cr; the largest is Biotech Consortium India Limited at ₹6.12 Cr (FY 2025).

Ram Vishwakarma is associated with 4 companies as Additional Director and Director, including Biotech Consortium India Limited (₹6.12 Cr), Conjuvac (Opc) Private Limited (₹1.13 Cr), Onco-Vac Biopharma Private Limited (₹28,383).

Ram Vishwakarma has expertise in Technology, General Business.

Ram Vishwakarma has 6 years in corporate governance.

By reported revenue, the largest current company of Ram Vishwakarma is Biotech Consortium India Limited, with revenue of ₹6.12 Cr (FY 2025).

The 3 current companies of Ram Vishwakarma that report revenue have a combined latest revenue of ₹7.25 Cr.

Ram Vishwakarma currently holds positions at 4 companies: Biotech Consortium India Limited (₹6.12 Cr), Conjuvac (Opc) Private Limited (₹1.13 Cr), Onco-Vac Biopharma Private Limited (₹28,383), Skei Oncotherapeutics Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available